Johnson & Johnson
Latest
Thousands to sue Johnson & Johnson in UK over alleged talc link to cancer
Lawyers representing 3,500 claimants are preparing to sue the pharmaceutical firm Johnson & Johnson (J&J) over alleged links between talcum powder and cancer, in what is expected to be one…
J&J to end global sales of talc-based baby powder
Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker announced, more than two years after it ended…
EU regulator backs J&J COVID-19 booster dose in adults
Dec 15 (Reuters) - The European Union's drug regulator on Wednesday recommended that a booster dose of Johnson & Johnson's COVID-19 vaccine…
Healthcare giant Johnson & Johnson to split into two companies
Nov 12 (Reuters) - Healthcare conglomerate Johnson & Johnson said on Friday it is planning to break up into two companies, splitting…
EU finds J&J COVID shot possibly linked to another rare clotting condition
Oct 1 (Reuters) - The European Union's drug regulator said on Friday there is a possible link between rare cases of bloods…
UPDATED: EU reviewing cases of rare body inflammation after COVID-19 shots
Europe's medicines regulator said on Friday it was reviewing if there was a risk of a rare inflammatory condition after inoculation with…
South African study shows J&J vaccine protects against death
Johnson & Johnson COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, the head of a…
EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine
Europe's medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from…
J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine sales
Johnson & Johnson raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine…
UPDATED: J&J’s COVID-19 vaccine shows promise against Delta variant
Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine showed promise against the highly contagious Delta variant in a laboratory…

